Harvard Bioscience (HBIO) Net Equity Issued and Repurchased (2010 - 2019)
Harvard Bioscience (HBIO) posted quarterly Net Equity Issued and Repurchased of -$58000.0 for Q3 2019, down 101.85% year-over-year from $3.1 million in Q3 2018, and down 166.67% quarter-over-quarter from $87000.0 in Q2 2019.
Harvard Bioscience (HBIO) Net Equity Issued and Repurchased (2010 - 2019) Analysis & Trends
Harvard Bioscience (HBIO) has reported Net Equity Issued and Repurchased for 10 consecutive years, with -$58000.0 the latest figure, recorded in Q3 2019.
- In Q3 2019, Net Equity Issued and Repurchased fell 101.85% year-over-year to -$58000.0; the TTM figure through Sep 2019 stood at -$356000.0 (down 107.44% YoY), while the FY2018 annual figure was $4.6 million, up 2748.12% from the prior year.
- Net Equity Issued and Repurchased retreated to -$58000.0 in Q3 2019 per HBIO's latest filing, from $87000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $3.1 million in Q3 2018 and bottomed at -$421000.0 in Q1 2019.
- Historically, Net Equity Issued and Repurchased has averaged $344684.2 across 5 years, with a median of $89000.0 in 2015.
- Annual changes were most pronounced in 2018 — Net Equity Issued and Repurchased surged 13187.5% — and 2019, when it plunged 292.24%.
- Harvard Bioscience's Net Equity Issued and Repurchased stood at $89000.0 in 2015, then advanced by 14.61% to $102000.0 in 2016, then soared by 155.88% to $261000.0 in 2017, then tumbled by 86.21% to $36000.0 in 2018, then tumbled by 261.11% to -$58000.0 in 2019.
- Business Quant data shows HBIO's Net Equity Issued and Repurchased at -$58000.0 in Q3 2019, $87000.0 in Q2 2019, and -$421000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 29.31 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -58,000.00 |
| Sep 30, 2019 | -58,000.00 |
| Jun 30, 2019 | 87,000.00 |
| Jun 30, 2019 | 87,000.00 |
| Mar 31, 2019 | -421,000.00 |
| Mar 31, 2019 | -421,000.00 |
| Dec 31, 2018 | 36,000.00 |
| Dec 31, 2018 | 36,000.00 |
| Sep 30, 2018 | 3.14 Mn |
| Sep 30, 2018 | 3.14 Mn |
| Jun 30, 2018 | 1.16 Mn |
| Jun 30, 2018 | 1.16 Mn |
| Mar 31, 2018 | 219,000.00 |
| Mar 31, 2018 | 219,000.00 |
| Dec 31, 2017 | 261,000.00 |
| Dec 31, 2017 | 261,000.00 |
| Sep 30, 2017 | -24,000.00 |
| Sep 30, 2017 | -24,000.00 |
| Jun 30, 2017 | 78,000.00 |
| Jun 30, 2017 | 78,000.00 |